Abstract
The addition of nitric oxide (NO), in the form of either donor compounds or nitric oxide gas, inhibits hormone-stimulated cAMP accumulation in N18TG2 cells. Hormone receptors and Gs are not targets of NO because forskolin-stimulated cAMP accumulation is also inhibited. The inhibitory effect of NO is not altered by pretreatment of cells with pertussis toxin, indicating that Gi is not mediating the effect of NO. cAMP accumulation in these cells is not altered by cell incubation with Ca++ionophore or calmidazolium, indicating that calmodulin is not the target for NO. Experiments also rule out changes in phosphodiesterase or cGMP as mediators of the effect of NO. Cell incubation with superoxide dismutase in the presence or absence of catalase indicate that nitric oxide is the reactive species. The inhibitory action of nitric oxide is readily reversed, allowing full recovery of hormone and forskolin stimulation within 20 min of incubation in the absence of nitric oxide. The sum of the data indicate that NO targets either the adenylyl cyclase itself, or a regulatory component distinct from G proteins or calmodulin, to inhibit activation of the enzyme.
Footnotes
-
Send reprint requests to: Claudette Klein, Ph.D., Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, 1402 South Grand Boulevard, St. Louis, MO 63104.
-
↵1 This work was supported by grants from the National Institutes of Health (DA03690 to A.H.) and the American Heart Association (Y.-P.T, C.K.). S.S. was supported by a James Peters Fellowship.
- Abbreviations:
- CaM
- calmodulin
- GBSS
- Gey’s balanced salt solution
- Gi
- guanine nucleotide binding protein that inhibits adenylyl cyclase
- Gs
- guanine nucleotide binding protein that stimulates adenylyl cyclase
- NO
- nitric oxide
- NOS
- nitric oxide synthetase
- PDE
- phosphodiesterase
- PG
- prostaglandin
- PTX
- pertussis toxin
- SIN-1
- 3-morpholinsydnominine
- SNP
- sodium nitroprusside
- SOD
- superoxide dismutase
- Received December 8, 1997.
- Accepted March 10, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|